Literature DB >> 30806370

Early Initiation of Steroid-sparing Drugs in Idiopathic Pulmonary Hemosiderosis.

Priyankar Pal1, Hriday De2, Prabhas Prasun Giri2, Nupur Ganguly2, Alolika Mandal2.   

Abstract

Idiopathic pulmonary hemosiderosis is conventionally treated with steroids, prolonged usage of which maybe deleterious and disease often recurs on tapering. We initiated hydroxy-chloroquine and azathioprine early in treatment along with steroids in seven children with idiopathic pulmonary hemosiderosis, and observed that early introduction of second line immunosuppressants helped in reducing disease flare and steroid toxicity without serious adverse effects.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30806370

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   3.839


  3 in total

1.  Pulmonary Nocardia infection in a child with idiopathic pulmonary hemosiderosis.

Authors:  Lu Qin; Fei-Zhou Zhang; Tong-Yu Yang; Xiao-Fen Tao; Lan-Fang Tang
Journal:  BMC Pulm Med       Date:  2021-05-29       Impact factor: 3.320

Review 2.  Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions.

Authors:  Biplab K Saha; Nils T Milman
Journal:  Clin Rheumatol       Date:  2020-11-12       Impact factor: 3.650

Review 3.  Idiopathic Pulmonary Hemosiderosis as a Mimic of Pulmonary Vasculitis: A Case Report and Review of the Literature.

Authors:  Mary Buckley; Heather Van Mater
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.